World Congress on Treatment and Research in Multiple Sclerosis
Subscribe to our Newsletter
World Congress on Treatment and Research in Multiple Sclerosis
About Montréal
General Information
About Conference
Who We Are
Montreal Convention Center (Palais des congrès
Official Carrier
Important Information
Contact Us
Printed Material
World Congress on Treatment and Research in Multiple Sclerosis

Social Events
Exhibitors and Sponsors
Instruction for Presenter
Call for Abstracts
CME Credits
Add on Meeting
Housing Map
Medias/Press Info

Late Breaking News

Late Breaking News abstracts containing important findings not available before the general abstract deadline may be submitted from July 1- 25, 2008. Note that abstracts submitted as late-breaking news will be subject to peer review. Please see the general abstract submission information below.

Up to six abstracts will be selected for platform presentations during the Late Breaking News session; some authors may be invited to give poster presentations as part of the regularly scheduled poster sessions. Authors will be notified by August 15, 2008 regarding the status of their submission.

Submit your abstract


The Scientific Program Committee welcomes the submission of abstracts for presentation at the World Congress on Treatment and Research in Multiple Sclerosis.

After February 4, if you have any difficulty with the submission process that you cannot resolve yourself, please e-mail ScholarOne Technical support at or call 1 (434) 817-2040 ext. 406 in the USA. ScholarOne technical support is available Monday through Friday from 08.30 to 17.30 Eastern Time (13.30-22.30 UTC)

Important 2008 Dates

February 1, 2008

Abstract submission site opens

April 27, 2008

Deadline postponed to Sunday, April 27, 23.59 Pacific time

June 9, 2008

Platform and poster presenters are notified

July 1, 2008

Site opens for late-breaking news abstracts

July 25, 2008

Site closes for late-breaking news abstracts

Abstract Submission Guidelines

Abstract Submission Categories

  • Disease Modifying Therapy
  • Epidemiology/Genetics
  • Experimental Disease Models
  • Imaging
  • Neuroimmunology
  • Neuropsychology/Neuropsychiatry
  • Pathology
  • Rehabilitation and Quality of Life
  • Surrogate Markers (non-MRI)
  • Symptom Management

Instructions for Authors

  • Abstract must be submitted online.
  • Abstracts must be submitted in English.
  • The presenting author must be the contact author.
  • The presenting author may only submit two abstracts for consideration.
  • Use a short specific title indicating the nature of the investigation. Do not include abbreviations in the title.
  • Abstract should clearly address the following points: background, objectives, methods, results, and conclusions.
  • Authors will be asked to select the category that best describes their abstract submission.
  • Abstracts must be 300 words or less.
  • Use generic drug names.
  • Standard abbreviations may be used without definition. Nonstandard abbreviations must be placed in parentheses after first use of the term in the abstract body.
  • Tables, figures, and references are not allowed.
  • Please plan to create and save the abstract using your customary word processor and to copy/paste the information onto the abstract processing site.
  • Proof-read your abstract to make sure it is accurate. If selected, it will be published as submitted.
  • Disclosure of conflict of interest (e.g., grant support, consultancy, membership on advisory councils, speaker's bureau, etc.) and source of funding is required.
  • Presenting authors whose abstracts are accepted for platform or poster presentations must register for the congress.
  • Poster presenters must be available and present to stand by their posters during their assigned poster sessions.
  • All accepted abstracts will be published in the journal “Multiple Sclerosis” and authors must agree to this stipulation in advance.
  • The author must certify that the abstract is not being considered for publication elsewhere and has not already been published elsewhere, in printed or electronic form prior to September 17, 2008.
  • Presenting authors must upload an image (MS Word document, gif, jpg or pdf) of their passport as proof of eligibility for select sessions, awards and prizes offered to young investigators (born on or after January 1, 1973).


Sessions, Awards and Prizes

Poster Prizes

Five prizes of CAD $1,000 will be awarded to the best poster presentations. Awardees will be invited to present a single PowerPoint slide and a 5-minute summary presentation (no questions and answers) during the plenary session on Saturday.

Opportunities for Young Scientific Investigators
(presenting authors born on or after January 1, 1973)

Young Scientific Investigator Sessions
Selected presenters will be invited to make a 15-minute presentation (including discussion). If you wish to be considered for this session, please click the appropriate check box during the online submission process.

Two prizes of CAD $1,500 for best platform presentations by young researchers will be awarded at the closing session.

Travel Awards
A limited number of travel grants will be available to young investigators-in-training whose abstracts are accepted for oral or poster presentations and who demonstrate need for the travel award. As part of their abstract submission, applicants must upload an image of a letter of attestation-of-need, written by their department chair and printed on official letterhead.








About Montréal About the Conference Contact UsPrinted MaterialHome